Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Journal of Clinical Pharmacology
|
December 3, 2022
Model-Informed Approach Supporting Drug Development and Regulatory Evaluation for Rare Diseases
Ruo-Jing Li, Lian Ma, Fang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2021
FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC
Erica C Nakajima, Nicole Drezner, Xiaoxue Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2023
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer
Sandra J Casak, M Naomi Horiba, Mengdie Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2021
FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma
Erica C Nakajima, Paz J Vellanki, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive Stage Small Cell Lung Cancer
Yufan Liu, Jeannette Nashed, Amy K Barone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2022
FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer
Elizabeth S Duke, Amy K Barone, Somak Chatterjee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Anand Shah, Erik Bloomquist, Shenghui Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2021
FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With <i>RET</i> Gene Mutations or Fusions
Janice Kim, Diana Bradford, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2023
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma
Michael I Barbato, Jeannette Nashed, Diana Bradford, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Journal of Clinical Pharmacology
|
December 3, 2022
Model-Informed Approach Supporting Drug Development and Regulatory Evaluation for Rare Diseases
Ruo-Jing Li, Lian Ma, Fang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2021
FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC
Erica C Nakajima, Nicole Drezner, Xiaoxue Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2023
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer
Sandra J Casak, M Naomi Horiba, Mengdie Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2021
FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma
Erica C Nakajima, Paz J Vellanki, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive Stage Small Cell Lung Cancer
Yufan Liu, Jeannette Nashed, Amy K Barone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2022
FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer
Elizabeth S Duke, Amy K Barone, Somak Chatterjee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Anand Shah, Erik Bloomquist, Shenghui Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2021
FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With <i>RET</i> Gene Mutations or Fusions
Janice Kim, Diana Bradford, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2023
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma
Michael I Barbato, Jeannette Nashed, Diana Bradford, et al.
Page
of 4